Investments in Advanced Manufacturing Technologies by CDMOs
In the last few decades, CDMOs have steadily established expertise and facilities to manufacture drugs at full scale. They have incorporated various methods for manufacturing drugs at the lowest possible operational cost. An increasing number of contract manufacturers are investing in continuous manufacturing methods as well to conventions in batch processing methods. Due to the availability of advanced technology, the major companies are planning to provide CDMO services for companies seeking technology development, processing and production services.
Also, to spur growth, the CDMO industry is taking on capital projects and investing in new technologies to share risks with manufacturers, in response to the high capacity utilization rates. As indicated by the higher utilization rates, they are also hiring more personnel. The manufacturing of highly potent active pharmaceutical ingredients (HPAPIs) requires complex manufacturing processes; advanced synthesis and formulation expertise; and special protective equipment, manufacturing sites, production processes, and management systems. Such strategic expansions, investments, and acquisitions by CDMOs have helped them increase their service offerings and expand their customer base while providing significant cross-selling opportunities.
Services Analysis
Drug development services, pharmaceutical manufacturing services, and biologic manufacturing services are all subcategories of the pharmaceutical contract manufacturing sector. Pharmaceutical manufacturers' limited financial resources, capacity constraints, the need to shorten time-to-market, complex manufacturing requirements, large investments in setting up manufacturing facilities, and the expanding pipeline have all contributed to this market segment's dominance of pharmaceutical contract manufacturing.
Large portions of this market can be attributed to the fact that pharmaceutical manufacturers have limited resources and therefore must turn to Pharmaceutical Contract manufacturing in order to cut down on time-to-market and meet the increasingly complex manufacturing needs that have resulted from the high costs of setting up manufacturing facilities as well as the ever-expanding pipeline. On the other hand, the biologics manufacturing segment is expected to grow at the highest rate owing to the growing demand for vaccines and biosimilars.
What are the Growth Drivers for Pharmaceutical Contract Manufacturing Market?
• Patent expiry and increasing demand for generic drugs
• Increasing investments in pharmaceutical R&D
• Investments In advanced manufacturing technologies by CDMOs
What are the Market Opportunities?
• Increasing demand for biological therapies
• Growth in the nuclear medicine sector
• Growing demand for cell and gene therapies
Discover how to stay ahead
Our 440+ page report provides 600+ tables and charts/graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Pharmaceutical Contract Manufacturing Market. See how to exploit the opportunities.
Forecasts to 2032 and other analyses reveal the commercial prospects
• In addition to revenue forecasting to 2032, our new study provides you with recent results, growth rates, and market shares.
• You find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints, and challenges), PEST Analysis, Porter’s Five Forces, SWOT Analysis, product profiles and commercial developments.
Discover sales predictions for the world market and sub-markets
By Services
• Pharmaceutical Manufacturing Services
- Pharmaceutical API Manufacturing Services
- Pharmaceutical FDF Manufacturing Services
• Drug Development Services
• Biologics contract manufacturing services
- Biologics API manufacturing services
- Biologics FDF manufacturing services
By End User
• Big Pharmaceutical Companies
• Small & Medium-Sized Pharmaceutical Companies
• Generic Pharmaceutical Companies
• Other End Users
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 4 regional and 14 leading national markets:
By Region
North America
• U.S.
• Canada
Europe
• Germany
• France
• UK
• Italy
• Spain
• Switzerland
• Rest of Europe
Asia Pacific
• China
• Japan
• India
• South Korea
• Rest of Asia Pacific
LAMEA
• Brazil
• Mexico
• Rest of LAMEA
Leading companies and the potential for market growth
Overall world revenue for Pharmaceutical Contract Manufacturing Market will surpass $126 billion in 2022, our work calculates. We predict strong revenue growth through to 2032. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
Prospects for established firms and those seeking to enter the market– including company profiles for 18 of the major companies involved in the Pharmaceutical Contract Manufacturing market. Some of the companies profiled in this report include AbbVie Inc., Abnova Corporation, Boehringer Ingelheim International GmbH, Catalent, Inc., Evonik Industries AG, Fujifilm Corporation, ICON PLC, Lonza Group Ltd., Piramal Pharma Solutions, Recipharm AB, Samsung Biologics, Siegfried Holding AG, Thermo Fisher Scientific Inc., Vetter Pharma International GmbH, and WuXiAppTec among other prominent players.
How the Pharmaceutical Contract Manufacturing Market report helps you
In summary, our 440+ page report provides you with the following knowledge:
• Revenue forecasts to 2032 for Pharmaceutical Contract Manufacturing Market, with forecasts for 3 services, and 4 end-users each forecasted at a global and regional level– discover the industry’s prospects, finding the most lucrative places for investments and revenues
• Revenue forecasts to 2032 for 4 regional and 14 key national markets– See forecasts for the Pharmaceutical Contract Manufacturing market in North America, Europe, Asia Pacific, and Rest of the World. These regional markets have been further bifurcated by countries including US, Canada, Brazil, Mexico, Germany, France, UK, Italy, Spain, China, India, Japan, Australia, South Korea, among other prominent economies.
• Prospects for established firms and those seeking to enter the market– including company profiles for 15 of the companies involved in the Pharmaceutical Contract Manufacturing Market. Some of the company’s profiled in this report include AbbVie Inc., Abnova Corporation, Boehringer Ingelheim International GmbH, Catalent, Inc., Evonik Industries AG, Fujifilm Corporation, ICON PLC, Lonza Group Ltd., Piramal Pharma Solutions, Recipharm AB, Samsung Biologics, Siegfried Holding AG, Thermo Fisher Scientific Inc., Vetter Pharma International GmbH, and WuXiAppTec among other prominent players.
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.
Information found nowhere else
With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Our study is for everybody needing commercial analyses for the Pharmaceutical Contract Manufacturing Market and leading companies. You will find data, trends, and predictions.
'
1 Report Overview
1.1 Introduction to Global Pharmaceutical Contract Manufacturing Market
1.2 Global Pharmaceutical Contract Manufacturing Market Definition
1.3 Why You Should Read This Report
1.4 What This Report Delivers
1.5 Key Questions Answered By This Analytical Report Include:
1.6 Who is This Report For?
1.7 Methodology
1.7.1 Primary Research
1.7.2 Secondary Research
1.7.3 Market Evaluation & Forecasting Methodology
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Reports
1.10 About
2 Executive Summary
3 Qualitative Analysis of the Global Pharmaceutical Contract Manufacturing Market
3.1 Market Dynamics
3.1.1 Drivers
3.1.1.1 Patent expiry and increasing demand for generic drugs
3.1.1.2 Increasing investments in pharmaceutical R&D
3.1.1.3 Investments in advanced manufacturing technologies by CDMOs
3.1.2 Restraints
3.1.2.1 Introduction of serialization
3.1.3 OPPORTUNITIES
3.1.3.1 Increasing demand for biological therapies
3.1.3.2 Growth in the nuclear medicine sector
3.1.3.3 Growing demand for cell and gene therapies
3.2 SWOT Analysis
3.3 PEST Analysis
3.3.1 Political
3.3.2 Economic
3.3.3 Sociocultural
3.3.4 Technological
3.4 Porter’s Five Forces Analysis
3.4.1 Moderate Bargaining Power of Supplier
3.4.2 High Bargaining Power of Buyer
3.4.3 Low Threat of New Entrants
3.4.4 Low Threat of Substitutes
3.4.5 High Intensity of Competitive Rivalry
3.5 COVID-19 Impact Analysis
3.5.1 V-Shaped Recovery
3.5.2 U-Shaped Recovery
3.5.3 L-Shaped Recovery
3.5.4 W-Shaped Recovery
4 Global Pharmaceutical Contract Manufacturing Market, by Services, 2022-2032
4.1 Global Pharmaceutical Contract Manufacturing Market Forecast by Services, 2022-2032
4.2 PHARMACEUTICAL MANUFACTURING SERVICES
4.2.1 Global Pharmaceutical Contract Manufacturing Market for Pharmaceutical Manufacturing Services by Region: Market Forecast, 2022-2032
4.2.2 COVID-19 Impact on Global Pharmaceutical Contract Manufacturing Market Forecast for Pharmaceutical Manufacturing Services: Recovery Scenarios (V, U, W, L)
4.2.3 PHARMACEUTICAL API MANUFACTURING SERVICES
4.2.3.1 Need to cut costs and ensure focus on core areas leads companies to outsource API manufacturing
4.2.3.2 Global Pharmaceutical Contract Manufacturing Market for Pharmaceutical API Manufacturing Services by Region: Market Forecast, 2022-2032
4.2.3.3 COVID-19 Impact on Global Pharmaceutical Contract Manufacturing Market Forecast for Pharmaceutical API Manufacturing Services: Recovery Scenarios (V, U, W, L)
4.2.4 PHARMACEUTICAL FDF MANUFACTURING SERVICES
4.2.4.1 Global Pharmaceutical Contract Manufacturing Market for Pharmaceutical FDF Manufacturing Services by Region: Market Forecast, 2022-2032
4.2.4.2 COVID-19 Impact on Global Pharmaceutical Contract Manufacturing Market Forecast for Pharmaceutical FDF Manufacturing Services: Recovery Scenarios (V, U, W, L)
4.2.4.3 Parenteral/Injectable manufacturing services
4.2.4.3.1 Need for high levels of expertise and growing drug development activities are driving the demand for contract manufacturing
4.2.4.3.2 Global Pharmaceutical Contract Manufacturing Market for Parenteral/injectable manufacturing services: Market Forecast, 2022-2032
4.2.4.4 Tablet manufacturing services
4.2.4.4.1 Shifting manufacturing requirements and the need to streamline production processes are driving market growth
4.2.4.4.2 Global Pharmaceutical Contract Manufacturing Market for Tablet manufacturing services: Market Forecast, 2022-2032
4.2.4.5 Capsule manufacturing services
4.2.4.5.1 Growth in demand for capsule formulations has ensured growth opportunities for service providers
4.2.4.5.2 Global Pharmaceutical Contract Manufacturing Market for Capsule manufacturing services: Market Forecast, 2022-2032
4.2.4.6 Oral liquid manufacturing services
4.2.4.6.1 Complexities involved in oral liquid manufacturing have prompted companies to opt for outsourcing
4.2.4.6.2 Global Pharmaceutical Contract Manufacturing Market for Oral liquid manufacturing services: Market Forecast, 2022-2032
4.2.4.7 Semi-solid manufacturing services
4.2.4.7.1 Demand for specific manufacturing facilities to boost the outsourcing of semi –solids
4.2.4.7.2 Global Pharmaceutical Contract Manufacturing Market for Semi-solid manufacturing services: Market Forecast, 2022-2032
4.2.4.8 Other Formulation manufacturing services
4.2.4.8.1 Demand for specific manufacturing facilities to boost the outsourcing of semi –solids
4.2.4.8.2 Global Pharmaceutical Contract Manufacturing Market for Other Formulation manufacturing services: Market Forecast, 2022-2032
4.3 Drug Development Services
4.3.1 Drug Substance Complexity And High Costs Have Supported The Outsourcing Of Drug Development
4.3.2 Global Pharmaceutical Contract Manufacturing Market for Drug Development Services: Market Forecast, 2022-2032
4.3.3 COVID-19 Impact on Global Pharmaceutical Contract Manufacturing Market Forecast for Drug Development Services: Recovery Scenarios (V, U, W, L)
4.4 Biologics Contract Manufacturing Services
4.4.1 Global Pharmaceutical Contract Manufacturing Market for Biologics contract manufacturing services: Market Forecast, 2022-2032
4.4.2 COVID-19 Impact on Global Pharmaceutical Contract Manufacturing Market Forecast for Biologics contract manufacturing services: Recovery Scenarios (V, U, W, L)
4.4.1 Biologics API Manufacturing Services
4.4.1.1 This market is still in the nascent phase
4.4.1.2 Global Pharmaceutical Contract Manufacturing Market for Biologics API Manufacturing Services by Region: Market Forecast, 2022-2032
4.4.1.3 COVID-19 Impact on Global Pharmaceutical Contract Manufacturing Market Forecast for Pharmaceutical Manufacturing Services: Recovery Scenarios (V, U, W, L)
4.4.2 Biologics FDF Manufacture Service
4.4.2.1 Increasing R&D costs and process complexity have prompted the shift toward contract manufacturing
4.4.2.2 Global Pharmaceutical Contract Manufacturing Market for Biologics FDF Manufacture Service by Region: Market Forecast, 2022-2032
4.4.2.3 COVID-19 Impact on Global Pharmaceutical Contract Manufacturing Market Forecast for Biologics FDF Manufacture Service: Recovery Scenarios (V, U, W, L)
5 Global Pharmaceutical Contract Manufacturing Market, by End User, 2022-2032
5.1 Global Pharmaceutical Contract Manufacturing Market Forecast by End User, 2022-2032
5.2 Big Pharmaceutical Companies
5.2.1 Global Pharmaceutical Contract Manufacturing Market for Big Pharmaceutical Companies by Region: Market Forecast, 2022-2032
5.2.2 COVID-19 Impact on Global Pharmaceutical Contract Manufacturing Market For Big pharmaceutical companies: Recovery Scenarios (V, U, W, L)
5.3 Small & Medium-Sized Pharmaceutical Companies
5.3.1 Growing Development Of Biologic Drugs And High Pricing Pressure To Boost Market Growth
5.3.2 Global Pharmaceutical Contract Manufacturing Market for Small & Medium-Sized Pharmaceutical Companies by Region: Market Forecast, 2022-2032
5.3.3 COVID-19 Impact on Global Pharmaceutical Contract Manufacturing Market For Small & Medium-Sized Pharmaceutical Companies: Recovery Scenarios (V, U, W, L)
5.4 Generic Pharmaceutical Companies
5.4.1 Growing Demand For Generics To Support Market Growth
5.4.2 Global Pharmaceutical Contract Manufacturing Market for Generic Pharmaceutical Companies by Region: Market Forecast, 2022-2032
5.4.3 COVID-19 Impact on Global Pharmaceutical Contract Manufacturing Market For Generic Pharmaceutical Companies: Recovery Scenarios (V, U, W, L)
5.5 Other End Users
5.5.1 Global Pharmaceutical Contract Manufacturing Market for Other End Users by Region: Market Forecast, 2022-2032
5.5.2 COVID-19 Impact on Global Pharmaceutical Contract Manufacturing Market For Other End Users: Recovery Scenarios (V, U, W, L)
6 North America Pharmaceutical Contract Manufacturing Market, 2022-2032
6.1.1 COVID-19 Impact on North America Pharmaceutical Contract Manufacturing Market: Recovery Scenarios (V, U, W, L)
6.2 North America Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032
6.2.1 North America Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032
6.2.2 North America Biologics Manufacturing Market Forecast, by Type, 2022-2032
6.3 North America Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032
6.4 North America Pharmaceutical Contract Manufacturing Market Forecast, by Country, 2022-2032
6.5 US
6.5.1 The US dominates the North American Pharmaceutical Contract manufacturing market
6.5.2 Increasing funding from Federal Government
6.5.3 U.S. Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032
6.5.4 US Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032
6.5.5 US Biologics Manufacturing Market Forecast, by Type, 2022-2032
6.5.6 US Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032
6.5.7 COVID-19 Impact on US Pharmaceutical Contract Manufacturing Market: Recovery Scenarios (V, U, W, L)
6.6 Canada
6.6.1 Rising incidence of chronic lifestyle diseases is expected to boost the market growth
6.6.2 Government initiatives to promote pharmaceutical contract manufacturing in various indications to drive market growth in Canada
6.6.3 Canada Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032
6.6.4 Canada Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032
6.6.5 Canada Biologics Manufacturing Market Forecast, by Type, 2022-2032
6.6.6 Canada Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032
6.6.7 COVID-19 Impact on Canada Pharmaceutical Contract Manufacturing Market: Recovery Scenarios (V, U, W, L)
7 Europe Pharmaceutical Contract Manufacturing Market, 2022-2032
7.1.1 COVID-19 Impact on Europe Pharmaceutical Contract Manufacturing Market: Recovery Scenarios (V, U, W, L)
7.2 Europe Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032
7.2.1 Europe Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032
7.2.2 Europe Biologics Manufacturing Market Forecast, by Type, 2022-2032
7.3 Europe Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032
7.4 Europe Pharmaceutical Contract Manufacturing Market Forecast, by Country, 2022-2032
7.5 Germany
7.5.1 High healthcare expenditure by the country
7.5.2 Increased pharmaceutical production to support market demand
7.5.3 Germany Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032
7.5.4 Germany Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032
7.5.5 Germany Biologics Manufacturing Market Forecast, by Type, 2022-2032
7.5.6 Germany Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032
7.5.7 COVID-19 Impact on Germany Pharmaceutical Contract Manufacturing Market: Recovery Scenarios (V, U, W, L)
7.6 UK
7.6.1 Growth In The Generics Market And The Rising Cost Of Manufacturing Parenteral Formulations Are Driving Market Growth
7.6.2 Increasing R&D research will boost the market
7.6.3 UK Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032
7.6.4 UK Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032
7.6.5 UK Biologics Manufacturing Market Forecast, by Type, 2022-2032
7.6.6 UK Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032
7.6.7 COVID-19 Impact on UK Pharmaceutical Contract Manufacturing Market: Recovery Scenarios (V, U, W, L)
7.7 Switzerland
7.7.1 Large volume of pharmaceutical production and growing scope for generics to provide growth opportunities
7.7.2 Switzerland boasts a strong research oriented pharma industry, a key factor supporting market growth.
7.7.3 Switzerland Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032
7.7.4 Switzerland Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032
7.7.5 Switzerland Biologics Manufacturing Market Forecast, by Type, 2022-2032
7.7.6 Switzerland Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032
7.7.7 COVID-19 Impact on Switzerland Pharmaceutical Contract Manufacturing Market: Recovery Scenarios (V, U, W, L)
7.8 France
7.8.1 Presence of leading pharmaceutical companies to support market growth in France
7.8.2 Availability of reimbursement
7.8.3 France Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032
7.8.4 France Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032
7.8.5 France Biologics Manufacturing Market Forecast, by Type, 2022-2032
7.8.6 France Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032
7.8.7 COVID-19 Impact on France Pharmaceutical Contract Manufacturing Market: Recovery Scenarios (V, U, W, L)
7.9 Italy
7.9.1 Increasing focus on clinical research and the growing popularity of branded drugs are driving the demand for contract development and manufacturing
7.9.2 Economic slowdown of Italian healthcare industry
7.9.3 Italy Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032
7.9.4 Italy Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032
7.9.5 Italy Biologics Manufacturing Market Forecast, by Type, 2022-2032
7.9.6 Italy Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032
7.9.7 COVID-19 Impact on Italy Pharmaceutical Contract Manufacturing Market: Recovery Scenarios (V, U, W, L)
7.10 Spain
7.10.1 Increase in biologics production to support market growth
7.10.2 Advancement in the production and research of innovative drugs
7.10.3 Spain Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032
7.10.4 Spain Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032
7.10.5 Spain Biologics Manufacturing Market Forecast, by Type, 2022-2032
7.10.6 Spain Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032
7.10.7 COVID-19 Impact on Spain Pharmaceutical Contract Manufacturing Market: Recovery Scenarios (V, U, W, L)
7.11 Rest of Europe
7.11.1 Rest of Europe Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032
7.11.2 Rest of Europe Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032
7.11.3 Rest of Europe Biologics Manufacturing Market Forecast, by Type, 2022-2032
7.11.4 Rest of Europe Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032
7.11.5 COVID-19 Impact on Rest of Europe Pharmaceutical Contract Manufacturing Market: Recovery Scenarios (V, U, W, L)
8 Asia-Pacific Pharmaceutical Contract Manufacturing Market, 2022-2032
8.1.1 COVID-19 Impact on Asia-Pacific Pharmaceutical Contract Manufacturing Market: Recovery Scenarios (V, U, W, L)
8.2 Asia-Pacific Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032
8.2.1 Asia-Pacific Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032
8.2.2 Asia-Pacific Biologics Manufacturing Market Forecast, by Type, 2022-2032
8.3 Asia-Pacific Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032
8.4 Asia-Pacific Pharmaceutical Contract Manufacturing Market Forecast, by Country, 2022-2032
8.5 Japan
8.5.1 Growing generics demand to drive the demand for contract manufacturing of drugs
8.5.2 Government initiatives to increase the use of generic drugs
8.5.3 Japan Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032
8.5.4 Japan Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032
8.5.5 Japan Biologics Manufacturing Market Forecast, by Type, 2022-2032
8.5.6 Japan Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032
8.5.7 COVID-19 Impact on Japan Pharmaceutical Contract Manufacturing Market: Recovery Scenarios (V, U, W, L)
8.6 China
8.6.1 Favourable government regulations are fuelling market growth in China
8.6.2 Strong focus of key market players to expand their business In China
8.6.3 China Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032
8.6.4 China Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032
8.6.5 China Biologics Manufacturing Market Forecast, by Type, 2022-2032
8.6.6 China Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032
8.6.7 COVID-19 Impact on China Pharmaceutical Contract Manufacturing Market: Recovery Scenarios (V, U, W, L)
8.7 India
8.7.1 Low manufacturing costs is attracting outsourcing
8.7.2 Presence of skilled workforce
8.7.3 India Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032
8.7.4 India Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032
8.7.5 India Biologics Manufacturing Market Forecast, by Type, 2022-2032
8.7.6 India Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032
8.7.7 COVID-19 Impact on India Pharmaceutical Contract Manufacturing Market: Recovery Scenarios (V, U, W, L)
8.8 South Korea
8.8.1 Government investments are a key contributor to market growth in South Korea
8.8.2 Increase in initiative of government research funding
8.8.3 South Korea Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032
8.8.4 South Korea Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032
8.8.5 South Korea Biologics Manufacturing Market Forecast, by Type, 2022-2032
8.8.6 South Korea Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032
8.8.7 COVID-19 Impact on South Korea Pharmaceutical Contract Manufacturing Market: Recovery Scenarios (V, U, W, L)
8.9 Rest of APAC
8.9.1 Singapore and Malaysia are major markets in Rest of APAC
8.9.2 Taiwan and Malaysia are some of the emerging countries
8.9.3 Rest of APAC Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032
8.9.4 Rest of APAC Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032
8.9.5 Rest of APAC Biologics Manufacturing Market Forecast, by Type, 2022-2032
8.9.6 Rest of APAC Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032
8.9.7 COVID-19 Impact on Rest of APAC Pharmaceutical Contract Manufacturing Market: Recovery Scenarios (V, U, W, L)
9 Latin America, Middle East & Africa (LAMEA) Pharmaceutical Contract Manufacturing Market, 2022-2032
9.1.1 COVID-19 Impact on LAMEA Pharmaceutical Contract Manufacturing Market: Recovery Scenarios (V, U, W, L)
9.2 LAMEA Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032
9.2.1 LAMEA Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032
9.2.2 LAMEA Biologics Manufacturing Market Forecast, by Type, 2022-2032
9.3 LAMEA Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032
9.4 LAMEA Pharmaceutical Contract Manufacturing Market Forecast, by Country, 2022-2032
9.5 Brazil
9.5.1 Increasing focus of BNCs on the pharmaceutical and healthcare sectors
9.5.2 Production-development partnerships have been implemented
9.5.3 Brazil Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032
9.5.4 Brazil Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032
9.5.5 Brazil Biologics Manufacturing Market Forecast, by Type, 2022-2032
9.5.6 Brazil Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032
9.5.7 COVID-19 Impact on Brazil Pharmaceutical Contract Manufacturing Market: Recovery Scenarios (V, U, W, L)
9.6 Mexico
9.6.1 One of the largest exporters of pharmaceutical products in Latin America
9.6.2 Increased focus among key players to expand their business in Mexico
9.6.3 Mexico Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032
9.6.4 Mexico Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032
9.6.5 Mexico Biologics Manufacturing Market Forecast, by Type, 2022-2032
9.6.6 Mexico Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032
9.6.7 Mexico
9.6.8 COVID-19 Impact on Mexico Pharmaceutical Contract Manufacturing Market: Recovery Scenarios (V, U, W, L)
9.7 Saudi Arabia
9.7.1 Largest pharmaceutical market in the Middle East
9.7.2 High-profile agreements and collaborations in the country
9.7.3 Saudi Arabia Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032
9.7.4 Saudi Arabia Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032
9.7.5 Saudi Arabia Biologics Manufacturing Market Forecast, by Type, 2022-2032
9.7.6 Saudi Arabia Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032
9.7.7 COVID-19 Impact on Saudi Arabia Pharmaceutical Contract Manufacturing Market: Recovery Scenarios (V, U, W, L)
9.8 Rest of LAMEA
9.8.1 Government initiatives to tackle the growing burden of pharmaceutical costs
9.8.2 Rest of LAMEA Pharmaceutical Contract Manufacturing Market Forecast, by Services, 2022-2032
9.8.3 Rest of LAMEA Pharmaceutical Manufacturing Services Market Forecast, by Type, 2022-2032
9.8.4 Rest of LAMEA Biologics Manufacturing Market Forecast, by Type, 2022-2032
9.8.5 Rest of LAMEA Pharmaceutical Contract Manufacturing Market Forecast, by End User, 2022-2032
9.8.6 COVID-19 Impact on Rest of LAMEA Pharmaceutical Contract Manufacturing Market: Recovery Scenarios (V, U, W, L)
10 Company Profiles
10.1 Market Share Analysis
10.2 LONZA GROUP
10.2.1 Company overview
10.2.2 Company Snapshot
10.2.3 Service Portfolio
10.2.4 Financial Analysis
10.2.4.1 Net Revenue, 2016-2020
10.2.4.2 Segmental Revenue Shares, 2020
10.2.4.3 Regional Revenue Shares, 2020
10.2.5 Recent Developments, 2017-2020
10.3 THERMO FISHER SCIENTIFIC INC.
10.3.1 Company overview
10.3.2 Company Snapshot
10.3.3 Service Portfolio
10.3.4 Financial Analysis Net Revenue, 2016-2020
10.3.4.1 Segmental Revenue Shares, 2020
10.3.4.2 Regional Revenue Shares, 2020
10.3.5 Recent Developments, 2018-2020
10.4 CATALENT
10.4.1 Company Overview
10.4.2 Company Snapshot
10.4.3 Service Portfolio
10.4.4 Financial Analysis
10.4.4.1 Net Revenue, 2016-2020
10.4.4.2 Segmental Revenue Shares, 2021
10.4.4.3 Regional Revenue Shares, 2021
10.4.5 Recent Developments, 2018-2020
10.5 RECIPHARM AB
10.5.1 Company Overview
10.5.2 Company Snapshot
10.5.3 Service Portfolio
10.5.4 Financial Analysis
10.5.4.1 Net Revenue, 2016-2020
10.5.4.2 Segmental Revenue Shares, 2020
10.5.5 Recent Developments, 2017-2020
10.6 ABBVIE
10.6.1 Company Overview
10.6.2 Company Snapshot
10.6.3 Service Portfolio
10.6.4 Financial Analysis
10.6.4.1 Net Revenue, 2016-2020
10.6.4.2 Segmental Revenue Shares, 2020
10.6.4.3 Regional Revenue Shares, 2020
10.6.5 Recent Developments, 2020
10.7 SIEGFRIED HOLDING AG
10.7.1 Company Overview
10.7.2 Company Snapshot
10.7.3 Service Portfolio
10.7.4 Financial Analysis
10.7.4.1 Net Revenue, 2016-2020
10.7.5 Recent Developments, 2019
10.8 EVONIK INDUSTRIES
10.8.1 Company Overview
10.8.2 Company Snapshot
10.8.3 Service Portfolio
10.8.4 Financial Analysis
10.8.4.1 Net Revenue, 2016-2020
10.8.4.2 Segmental Revenue Shares, 2020
10.8.4.3 Regional Revenue Shares, 2019
10.8.5 Recent Developments, 2020
10.9 BOEHRINGER INGELHEIM
10.9.1 Company Overview
10.9.2 Company Snapshot
10.9.3 Service Portfolio
10.9.4 Financial Analysis
10.9.4.1 Net Revenue, 2016-2020
10.9.4.2 Segmental Revenue Shares, 2020
10.9.4.3 Regional Revenue Shares, 2020
10.9.5 Recent Developments, 2017-2019
10.10 PIRAMAL PHARMA SOLUTIONS
10.10.1 Company Overview
10.10.2 Company Snapshot
10.10.3 Service Portfolio
10.10.4 Financial Analysis
10.10.4.1 Net Revenue, 2017-2021
10.10.4.2 Segmental Revenue Shares, 2021
10.10.4.3 Regional Revenue Shares, 2021
10.10.5 Recent Developments, 2020
10.11 SAMSUNG BIOLOGICS
10.11.1 Company Overview
10.11.2 Company Snapshot
10.11.3 Service Portfolio
10.11.4 Financial Analysis
10.11.4.1 Segmental Revenue Shares, 2020
10.11.4.2 Regional Revenue Shares, 2020
10.11.5 Recent Developments, 2017-2020
10.12 WUXI APPTEC (WUXI STA)
10.12.1 Company Overview
10.12.2 Company Snapshot
10.12.3 Service Portfolio
10.12.4 Recent Developments, 2018-2020
10.13 FUJIFILM HEALTHCARE
10.13.1 Company Overview
10.13.2 Company Snapshot
10.13.3 Service Portfolio
10.13.4 Financial Analysis
10.13.4.1 Net Revenue, 2016-2019
10.13.4.2 Segmental Revenue Shares, 2019
10.13.4.3 Regional Revenue Shares, 2019
10.13.5 Recent Developments, 2017-2018
10.14 ICON PLC
10.14.1 Company Overview
10.14.2 Company Snapshot
10.14.3 Service Portfolio
10.15 ABNOVA CORPORATION
10.15.1 Company Overview
10.15.2 Company Snapshot
10.15.3 Service Portfolio
10.16 VETTER PHARMA INTERNATIONAL
10.16.1 Company Overview
10.16.2 Company Snapshot
10.16.3 Service Portfolio
11 Conclusion and Recommendations
11.1 Concluding Remarks from
11.2 Recommendations for Market Players
11.3 Leading and Fastest Growing Region
List of Tables
Table 1 Global Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "V" Shaped Recovery
Table 2 Global Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "U" Shaped Recovery
Table 3 Global Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "L" Shaped Recovery
Table 4 Global Pharmaceutical Contract Manufacturing Market Forecast, 2022-2032 (US$ billion, AGR%, CAGR%): "W" Shaped Recovery
Table 5 Global Pharmaceutical Contract Manufacturing Market Forecast by Services, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 6 Global Pharmaceutical Contract Manufacturing Market Forecast For Pharmaceutical Manufacturing Services by Region, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 7 Global Pharmaceutical Contract Manufacturing Market Forecast For Pharmaceutical Manufacturing Services, 2022-2032 (US$ billion, AGR%, CAGR%): V-Shaped Recovery
Table 8 Global Pharmaceutical Contract Manufacturing Market Forecast For Pharmaceutical Manufacturing Services, 2022-2032 (US$ billion, AGR%, CAGR%): U-Shaped Recovery
Table 9 Global Pharmaceutical Contract Manufacturing Market Forecast for Pharmaceutical Manufacturing Services, 2022-2032 (US$ billion, AGR%, CAGR%): L-Shaped Recovery
Table 10 Global Pharmaceutical Contract Manufacturing Market Forecast for Pharmaceutical Manufacturing Services, 2022-2032 (US$ billion, AGR%, CAGR%): W-Shaped Recovery
Table 11 Global Pharmaceutical Contract Manufacturing Market Forecast For Pharmaceutical API Manufacturing Services by Region, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 12 Global Pharmaceutical Contract Manufacturing Market Forecast For Pharmaceutical API Manufacturing Services, 2022-2032 (US$ billion, AGR%, CAGR%): V-Shaped Recovery
Table 13 Global Pharmaceutical Contract Manufacturing Market Forecast for Pharmaceutical API Manufacturing Services, 2022-2032 (US$ billion, AGR%, CAGR%): U-Shaped Recovery
Table 14 Global Pharmaceutical Contract Manufacturing Market Forecast for Pharmaceutical API Manufacturing Services, 2022-2032 (US$ billion, AGR%, CAGR%): L-Shaped Recovery
Table 15 Global Pharmaceutical Contract Manufacturing Market Forecast for Pharmaceutical API Manufacturing Services, 2022-2032 (US$ billion, AGR%, CAGR%): W-Shaped Recovery
Table 16 Global Pharmaceutical Contract Manufacturing Market Forecast For Pharmaceutical FDF Manufacturing Services by Region, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 17 Global Pharmaceutical Contract Manufacturing Market Forecast For Pharmaceutical FDF Manufacturing Services, 2022-2032 (US$ billion, AGR%, CAGR%): V-Shaped Recovery
Table 18 Global Pharmaceutical Contract Manufacturing Market Forecast for Pharmaceutical FDF Manufacturing Services, 2022-2032 (US$ billion, AGR%, CAGR%): U-Shaped Recovery
Table 19 Global Pharmaceutical Contract Manufacturing Market Forecast for Pharmaceutical FDF Manufacturing Services, 2022-2032 (US$ billion, AGR%, CAGR%): L-Shaped Recovery
Table 20 Global Pharmaceutical Contract Manufacturing Market Forecast for Pharmaceutical FDF Manufacturing Services, 2022-2032 (US$ billion, AGR%, CAGR%): W-Shaped Recovery
Table 21 Global Pharmaceutical Contract Manufacturing Market Forecast For Parenteral/injectable manufacturing services, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 22 Global Pharmaceutical Contract Manufacturing Market Forecast For Tablet manufacturing services, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 23 Global Pharmaceutical Contract Manufacturing Market Forecast For Capsule manufacturing services, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 24 Global Pharmaceutical Contract Manufacturing Market Forecast For Oral liquid manufacturing services, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 25 Global Pharmaceutical Contract Manufacturing Market Forecast For Semi-solid manufacturing services, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 26 Global Pharmaceutical Contract Manufacturing Market Forecast For Other Formulation manufacturing services, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 27 Global Pharmaceutical Contract Manufacturing Market Forecast For Drug Development Services, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 28 Global Pharmaceutical Contract Manufacturing Market Forecast For Drug Development Services, 2022-2032 (US$ billion, AGR%, CAGR%): V-Shaped Recovery
Table 29 Global Pharmaceutical Contract Manufacturing Market Forecast for Drug Development Services, 2022-2032 (US$ billion, AGR%, CAGR%): U-Shaped Recovery
Table 30 Global Pharmaceutical Contract Manufacturing Market Forecast for Drug
Figure 44. Development Services, 2022-2032 (US$ billion, AGR%, CAGR%): L-Shaped Recovery
Table 31 Global Pharmaceutical Contract Manufacturing Market Forecast for Drug Development Services, 2022-2032 (US$ billion, AGR%, CAGR%): W-Shaped Recovery
Table 32 Global Pharmaceutical Contract Manufacturing Market Forecast For Biologics contract manufacturing services, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 33 Global Pharmaceutical Contract Manufacturing Market Forecast For Biologics contract manufacturing services, 2022-2032 (US$ billion, AGR%, CAGR%): V-Shaped Recovery
Table 34 Global Pharmaceutical Contract Manufacturing Market Forecast for Biologics contract manufacturing services, 2022-2032 (US$ billion, AGR%, CAGR%): U-Shaped Recovery
Table 35 Global Pharmaceutical Contract Manufacturing Market Forecast for Biologics contract manufacturing services, 2022-2032 (US$ billion, AGR%, CAGR%): L-Shaped Recovery
Table 36 Global Pharmaceutical Contract Manufacturing Market Forecast for Biologics contract manufacturing services, 2022-2032 (US$ billion, AGR%, CAGR%): W-Shaped Recovery
Table 37 Global Pharmaceutical Contract Manufacturing Market Forecast For Pharmaceutical Manufacturing Services by Region, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 38 Global Pharmaceutical Contract Manufacturing Market Forecast For Biologics API Manufacturing Services, 2022-2032 (US$ billion, AGR%, CAGR%): V-Shaped Recovery
Table 39 Global Pharmaceutical Contract Manufacturing Market Forecast for Biologics API Manufacturing Services, 2022-2032 (US$ billion, AGR%, CAGR%): U-Shaped Recovery
Table 40 Global Pharmaceutical Contract Manufacturing Market Forecast for Biologics API Manufacturing Services, 2022-2032 (US$ billion, AGR%, CAGR%): L-Shaped Recovery
Table 41 Global Pharmaceutical Contract Manufacturing Market Forecast for Biologics API Manufacturing Services, 2022-2032 (US$ billion, AGR%, CAGR%): W-Shaped Recovery
Table 42 Global Pharmaceutical Contract Manufacturing Market Forecast For Biologics FDF Manufacture Service by Region, 2022-2032 (US$ billion, AGR%, CAGR %)
Table 43 Global Pharmaceutical Contract Manufacturing Market Forecast For Biologics FDF Manufacture Service, 2022-2032 (US$ billion, AGR%, CAGR%) : V-Shaped Recovery
Table 44 Global Pharmaceutical Contract Manufacturing Market Forecast for Biologics FDF Manufacture Service, 2022-2032 (US$ billion, AGR%, CAGR%): U-Shaped Recovery
Table 45 Global Pharmaceutical Contract Manufacturing Market Forecast for Biologics FDF Manufacture Service, 2022-2032 (US$ billion, AGR%, CAGR%): L-Shaped Recovery
Table 46 Global Pharmaceutical Contract Manufacturing Market Forecast for Biologics FDF Manufacture Service, 2022-2032 (US$ billion, AGR%, CAGR%): W-Shaped Recovery
Table 47 Global
